Alan Fournier's portfolio and holdings - Jan 2024

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 36 stocks with a net worth of over US$ 441.3 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Add Superstar Alert
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Agenus Inc Pennant Investors Lp 6.07 469,600 0.11% NEW 2.9 M
Agios Pharmaceuticals Inc Pennant Investors Lp 36.07 15,100 0.03% NEW 544.7 K
Allogene Therapeutics Inc Pennant Investors Lp 1.19 128,400 0.08% NEW 152.8 K
Altimmune Inc Pennant Investors Lp 4.76 109,800 0.15% NEW 522.6 K
Amazon.com Inc. Pennant Investors Lp 223.41 348,000 0.00% 0.00 77.7 M
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 13.78 13,100 0.05% NEW 180.5 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 13.82 170,900 0.15% NEW 2.4 M
BioXcel Therapeutics Inc Pennant Investors Lp 1.93 83,900 0.23% NEW 161.9 K
Coherus Biosciences Inc Pennant Investors Lp 0.81 168,100 0.15% NEW 136.2 K
Compass Therapeutics Inc Pennant Investors Lp 2.78 199,000 0.14% NEW 553.2 K
Enanta Pharmaceuticals Inc Pennant Investors Lp 7.89 35,100 0.17% NEW 276.9 K
Erasca Inc Pennant Investors Lp 1.44 166,200 0.11% NEW 239.3 K
89bio Inc Pennant Investors Lp 10.16 44,500 0.05% NEW 452.1 K
Fate Therapeutics Inc Pennant Investors Lp 1.12 146,100 0.13% NEW 163.6 K
FibroGen Inc Pennant Investors Lp 5.61 768,400 0.77% NEW 4.3 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 179.53 375,000 0.00% 0.00 67.3 M
IGM Biosciences Inc Pennant Investors Lp 1.36 64,900 0.11% NEW 88.3 K
Kalaris Therapeutics Inc. Pennant Investors Lp 2.50 215,700 0.19% NEW 539.3 K
Seres Therapeutics Inc Pennant Investors Lp 11.87 292,300 0.19% NEW 3.5 M
Macrogenics Inc Pennant Investors Lp 1.46 43,800 0.07% NEW 63.9 K
Microsoft Corporation Pennant Investors Lp 498.84 129,000 0.00% 0.00 64.4 M
Micron Technology Inc. Pennant Investors Lp 122.29 306,000 0.03% 0.00 37.4 M
Nurix Therapeutics Inc Pennant Investors Lp 12.73 56,800 0.09% NEW 723.1 K
Novavax, Inc. Pennant Investors Lp 6.80 60,300 0.04% NEW 410.0 K
ODP Corporation (The) Pennant Investors Lp 19.66 400,000 1.10% 0.02 7.9 M
uniQure N.V. Pennant Investors Lp 14.42 48,500 0.10% NEW 699.4 K
Replimune Group Inc Pennant Investors Lp 9.40 30,500 0.05% NEW 286.7 K
Relay Therapeutics Inc Pennant Investors Lp 3.63 42,400 0.03% NEW 153.9 K
Sage Therapeutics Inc Pennant Investors Lp 9.20 17,500 0.03% NEW 161 K
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 31.36 2,153,209 0.79% NEW 67.5 M
Travere Therapeutics Inc Pennant Investors Lp 15.01 55,800 0.07% NEW 837.6 K
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.26 32,400 0.05% NEW 40.8 K
Zymeworks BC Inc Pennant Investors Lp 13.04 38,700 0.05% NEW 504.6 K
Antero Resources Corp Pennant Investors Lp 37.26 913,000 0.29% -0.01 34.0 M
Arcus Biosciences Inc Pennant Investors Lp 8.47 23,700 0.03% NEW 200.7 K
Transdigm Group Incorporated Pennant Investors Lp 1522.98 42,000 0.08% 0.00 64.0 M
View All The Superstar Shareholder Portfolios